New Product Launches and Approvals
In January 2024, Movano Health had released outcomes of its blood tension clinical study sanctioned by the Institutional Review Board (IRB). The company’s prototype with integrated System-on-Chip (SoC) has reached the accuracy level required by the Food and Drug Administration (FDA) for blood pressure monitoring devices.
Valencell announced plans to introduce a line of branded products under the digital health category during its announcement in January 2023, justifying it as an innovative way to bring reverse solutions for chronic diseases. Valencell will also be the first cuff-less, calibration-free blood pressure monitor that can fit on a fingertip on Earth. This solution may be applied independently as a BP monitor. However, when used together with an app, this device is anticipated to have significant importance in HTN control.
For example, InBody introduced the new automatic BP monitor BP170 allowing self-recording and tracking of key health measurements at home during February 2022. Similarly, increasing adoption of home care health monitoring along with an increased focus on early diagnosis of hypertension & cardiac diseases is further expected to push up growth in the market.
In February 2020, Hillrom announced the commercial release of a new device called Welch Allyn Spot Vital Signs 4400, which is an easy-to-use next-generation vital signs monitor used to enhance hypertension detection in ambulatory & emergency department settings.
Strategic Collaborations and Acquisitions
In August 2023, Spacelabs Healthcare took part in the AHA’s Hypertension Scientific Sessions 2023. The firm stated how vital 24-hour ambulatory blood pressure monitoring is to managing hypertension better than any other method as it enables more accurate prediction of heart and vascular diseases, morbidity as well as mortality rates.
Hillrom acquired contact-free continuous monitoring technology from EarlySense at a sum of $30 million dollars, according to the company’s announcement last year around February. Consequently, this acquisition will enable Hillrom to develop next-gen AI-based sensing technologies specifically designed for remote patient care business.
Biobeat launched wearable chest-mounted continuous ABPM systems this May 1.
Blood Pressure Test Market Trends
The blood pressure test market is driven by rising prevalence of chronic diseases such as cardiovascular diseases, hypertension, diabetes, and others. Furthermore, changing lifestyle, and increasing demand for diagnostic devices for cardiovascular diseases is facilitating the market growth.
However, a limited number of trained personnel has restrained the growth of the market. However, the high cost of diagnosis and treatment of cardiovascular diseases restrains the growth of the market.
According to the WHO, about 59% of the mortality is due to chronic diseases, and almost 35 million people die of chronic diseases in the world. Cardiovascular diseases and diabetes are increasing the economic burden of various developing and developed nations across the globe.
Intended Audience
- Medical Device Manufacturers
- Medical Device Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Blood Pressure Test Market Segment Insights
The blood pressure test market is segmented on the basis of product, indication, and end user.
Product Segmentation
On the basis of the product, the blood pressure test market is segmented into sphygmomanometers, blood pressure transducers, blood pressure instrument accessories, and others.
Sphygmomanometers is further segmented into mercury, aneroid and digital. Blood pressure transducers is further segmented into disposable and reusable. Blood pressure instrument accessories is further segmented into blood pressure cuffs, bladders, and bulbs & valve.
Indication Segmentation
On the basis of indication, the blood pressure test market is segmented into hypertension, coronary heart disease, and others.
End User Segmentation
On the basis of the end user, the blood pressure test market is segmented into hospitals & clinics, diagnostic centers, home care and others.
Blood Pressure Test Regional Insights
The Americas
The Americas account for the largest blood pressure test market. Increasing prevalence of cardiovascular diseases and diabetes is the major driving factor for the growth of the market. According to the Center for Diseases Control and Prevention (CDC), 9.3% of the total American population is suffering from diabetes.
Increasing number of diabetic and obese population, rising demand for better treatment for the diseases and well-developed infrastructure has provided fuel for the growth of the market. North America accounts for the major share in the America advanced blood pressure test market.
Europe
Europe accounts for the second largest market due to the well-developed healthcare sector, continuously increasing patient population, and high healthcare expenditure. Additionally, increasing prevalence of diabetes in the European Union (EU) also fuels the market growth. Germany, the U.K., and France hold the first, second and third position in the market.
Asia Pacific
Asia Pacific is expecting the fastest growth for this market. Increasing prevalence of cardiovascular diseases and rising geriatric population are the major driving factor for the growth of the market. India and China are the two major regions with the highest contribution to the market growth owing to highest diabetic population and increasing the presence of heart attack among these patients. Additionally, rising geriatric population further drive the growth of the market.
Furthermore, rapid development of the healthcare infrastructure also accelerates the market growth. According to the International diabetic federation, India and China account 180 million people have diabetes which is approximately 40% of world’s diabetic population. The rising prevalence of diabetes in this region is attributed to rising prevalence of lifestyle disorders such as obesity, and addiction such as smoking. According to the International Diabetes Foundation, 98.4 million and 65.1 million diabetic population live in China and India respectively.
Middle East & Africa
In the Middle East & Africa, the market is expected to show steady growth due to developing healthcare system, and increasing demand for diagnostic and treatment services. The Middle East is the major contributor to the market which is driven by the presence of well-developed economies such as Kuwait and Qatar.
Whereas, Africa exhibits slow growth due to limited development in the field of medical science and presence of poor economic conditions in various developing regions of Africa.
Key Players in the Blood Pressure Test Market
Some of the key players in blood pressure test market are:
- OMRON Corporation
- SunTech Medical, Inc.
- SPENGLER
- Schiller AG
- Spacelabs Healthcare
- American Diagnostic Corporation
- Bosch + Sohn GmbH u. Co. KG
- Withings SA, Welch Allyn, Inc
- A&D Medical
- Koninklijke Philips N.V.
- General Electric Company
Blood Pressure Test Market Industry Developments
-
Q2 2024: Omron Healthcare Launches New Generation of Blood Pressure Monitors with Advanced AI Capabilities Omron Healthcare announced the commercial launch of its next-generation blood pressure monitors featuring integrated artificial intelligence for improved accuracy and personalized health insights. The new devices are now available in the U.S. and select European markets.
-
Q2 2024: Withings Receives FDA Clearance for BPM Core, a Smart Blood Pressure Monitor with ECG and Digital Stethoscope Withings announced it has received FDA clearance for its BPM Core device, which combines blood pressure monitoring, electrocardiogram, and digital stethoscope functions in a single home-use device, enabling advanced cardiovascular screening.
-
Q3 2024: Hillrom Expands Blood Pressure Device Manufacturing with New Facility in Texas Hillrom, a Baxter company, opened a new manufacturing facility in Texas dedicated to the production of advanced blood pressure monitoring devices, aiming to meet rising demand in North America.
-
Q3 2024: A&D Medical Partners with Teladoc Health to Integrate Connected Blood Pressure Monitors into Virtual Care Platform A&D Medical announced a strategic partnership with Teladoc Health to integrate its connected blood pressure monitors into Teladoc’s virtual care ecosystem, enhancing remote patient monitoring capabilities for hypertension management.
-
Q4 2024: Microlife Receives CE Mark for New Ambulatory Blood Pressure Monitoring System Microlife announced it has received CE Mark approval for its latest ambulatory blood pressure monitoring system, enabling expanded distribution across the European Union.
-
Q4 2024: Qardio Raises $30 Million in Series C Funding to Accelerate Blood Pressure Device Innovation Qardio, a digital health company specializing in connected blood pressure monitors, closed a $30 million Series C funding round to support product development and global expansion.
-
Q1 2025: Philips Launches Next-Gen Wearable Blood Pressure Monitor for Home and Clinical Use Philips introduced a new wearable blood pressure monitor designed for both home and clinical environments, featuring continuous monitoring and cloud-based analytics for improved hypertension management.
-
Q1 2025: Masimo Acquires Blood Pressure Device Maker SunTech Medical for $250 Million Masimo announced the acquisition of SunTech Medical, a leading provider of non-invasive blood pressure monitoring technology, in a $250 million deal to expand its patient monitoring portfolio.
-
Q2 2025: Omron Healthcare Receives FDA Clearance for Remote Blood Pressure Monitoring Platform Omron Healthcare received FDA clearance for its new remote blood pressure monitoring platform, enabling healthcare providers to monitor patients’ blood pressure data in real time and intervene proactively.
-
Q2 2025: iHealth Labs Partners with CVS Health to Supply Connected Blood Pressure Monitors Nationwide iHealth Labs announced a nationwide partnership with CVS Health to supply its connected blood pressure monitors in CVS retail locations and through the CVS online platform.
-
Q3 2025: Apple Hires Former Medtronic Executive to Lead Blood Pressure Technology Development Apple appointed a former Medtronic executive to head its blood pressure technology division, signaling a strategic push into the digital health and wearable blood pressure monitoring market.
-
Q3 2025: GE HealthCare Wins Major Hospital Contract for Advanced Blood Pressure Monitoring Systems in Germany GE HealthCare secured a multi-year contract to supply advanced blood pressure monitoring systems to a leading hospital network in Germany, strengthening its presence in the European medical device market.
Leave a Comment